632 related articles for article (PubMed ID: 35366105)
1. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.
Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
Cell Mol Life Sci; 2022 Apr; 79(4):219. PubMed ID: 35366105
[TBL] [Abstract][Full Text] [Related]
2. Colony Stimulating Factor-1 Receptor: An emerging target for neuroinflammation PET imaging and AD therapy.
Adhikari A; Chauhan K; Adhikari M; Tiwari AK
Bioorg Med Chem; 2024 Feb; 100():117628. PubMed ID: 38330850
[TBL] [Abstract][Full Text] [Related]
3. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders.
Tarale P; Alam MM
Inflammopharmacology; 2022 Jun; 30(3):821-842. PubMed ID: 35290551
[TBL] [Abstract][Full Text] [Related]
4. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
5. A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.
Kaushik DK; Basu A
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):726-40. PubMed ID: 24070095
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
7. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
8. Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia.
Walker DG; Tang TM; Lue LF
Front Aging Neurosci; 2017; 9():244. PubMed ID: 28848420
[TBL] [Abstract][Full Text] [Related]
9. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
11. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
Yang J; Li H; Zhao Y
Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
13. Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System.
Zhang H; Dai S; Yang Y; Wei J; Li X; Luo P; Jiang X
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238605
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
15. IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases.
Alberini CM
Trends Neurosci; 2023 Jun; 46(6):488-502. PubMed ID: 37031050
[TBL] [Abstract][Full Text] [Related]
16. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Brkic M; Balusu S; Libert C; Vandenbroucke RE
Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases.
Azman KF; Zakaria R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743271
[TBL] [Abstract][Full Text] [Related]
18. T Cells: A Growing Universe of Roles in Neurodegenerative Diseases.
Dressman D; Elyaman W
Neuroscientist; 2022 Aug; 28(4):335-348. PubMed ID: 34160330
[TBL] [Abstract][Full Text] [Related]
19. Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.
Heinzelman P; Priebe MC
Biotechnol Prog; 2015; 31(3):668-77. PubMed ID: 25737095
[TBL] [Abstract][Full Text] [Related]
20. Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
Huang J; Huang N; Xu S; Luo Y; Li Y; Jin H; Yu C; Shi J; Jin F
J Nutr Biochem; 2021 Feb; 88():108552. PubMed ID: 33220405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
